The Effect of Gynecological Cancers on Quality of Life and Nursing Approach

Öz

Gynecological cancers are among the common chronic diseases in women in the world and in our country. Women may experience many symptoms as a result of cancer and its treatments. These symptoms affect the woman's physical, psychological, cognitive and role functioning areas. The woman may experience a range of issues such as pain, fatigue, anxiety, depression, and sexual dysfunction. As a result, the woman's quality of life is negatively affected and the woman's adaptation the cancer diagnosis and ability to cope with cancer decreases. As a result, the woman's quality of life is negatively affected and the woman's adaptation the cancer diagnosis and ability to cope with cancer decreases. For this reason, it is important for nurses to be aware of the symptoms that may occur with cancer diagnosis and treatment and to be able to plan and implement interventions specific to the individual's needs in order to prevent or reduce the impact of these symptoms experienced by women in the light of evidence-based guidelines. This approach plays a major role in improving the quality of life of women and their families.

Anahtar Kelimeler

• Women’s health
• Gynecological cancers
• Quality of life
• Nursing

Jinekolojik Kanserlerin Yaşam Kalitesine Etkisi ve Hemşirelik Yaklaşımı

Öz

Jinekolojik kanserler dünyada ve ülkemizde kadınlarda yaygın görülen kronik hastalıklar arasında yer almaktadır. Kanser ve tedavileri sonucunda kadınlar birçok semptom yaşayabilmektedir. Bu semptomlar kadını fiziksel, psikolojik, bilişsel ve rol fonksiyon alanlarını etkilemektedir. Kadın, ağrı, yorgunluk, anksiyete, depresyon, cinsel işlev bozukluğu gibi bir dizi sorun yaşayabilmektedir. Bunun sonucunda, kadının yaşam kalitesi olumsuz yönde etkilenmekte ve kadının kanser tanısı ile uyumu ve kanserle baş etme yeteneği azalmaktadır. Bu nedenle hemşirelerin, kanser tanısı ve tedavisi ile birlikte meydana gelebilecek semptomların farkında olarak, kadınların yaşadıkları bu semptomları kanıta dayalı rehberler ışığında önleyebilmesi ya da etkisini azaltabilmesi için bireyin gereksinimlerine özgü girişimler planlayabilmesi ve uygulayabilmesi önem taşımaktadır. Bu yaklaşım, kadının ve ailesinin yaşam kalitesini artırmada büyük bir rol oynamaktadır.

Anahtar Kelimeler

• kadın sağlığı
• Kadın
• kanser
• hemşirelik
• bakım

Kaynakça

1. 1. Who Health Organization [Internet]. Global health estimates: Leading causes of death. 2020 [cited 2024 Feb 15]. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
2. 2. Piechocki M, Koziołek W, Sroka D, Matrejek A, Miziołek P, Saiuk N, et al. Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018). Clin Epidemiol. 2022;24:14:95-114. doi: 10.2147/CLEP.S330081
3. 3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA CANCER J CLIN 2021;71:209–249. doi:10.3322/caac.21660
4. 4. T.C. Sağlık Bakanlığı [Internet]. Türki̇ye kanser i̇stati̇sti̇kleri̇ 2018 Ankara; 2022. [cited 2024 Feb 15]. Available from: https://dergipark.org.tr/tr/pub/tjhr/writing-rules
5. 5. Spagnoletti BRM, Bennett LR, Keenan C, Shetty SS, Manderson L, McPake B, et al. What factors shape quality of life for women affected by gynaecological cancer in South, South East and East Asian countries? A critical review. Reprod Health. 2022;19(1):70. doi: 10.1186/s12978-022-01369-y
6. 6. Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28(10):2641-2650. doi: 10.1007/s11136-019-02214-9
7. 7. Who Health Organization [Internet]. WHOQOL - Measuring Quality of Life| The World Health Organization 2012 [cited 2024 Apr 8]. Available from: https://www.who.int/tools/whoqol
8. 8. National Cancer Instıtute [Internet]. Definition of quality of life - NCI Dictionary of Cancer Terms-NCI. 2024 [cited 2024 Apr 8]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/quality-of-life

9. 9. Ramasubbu SK, Pasricha RK, Nath UK, Rawat VS, Das B. Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital. Cancer Rep (Hoboken). 2021;4(2):e1312. doi: 10.1002/cnr2.1312
10. 10. Haddou Rahou B, El Rhazi K, Ouasmani F, Nejjari C, Bekkali R, Montazeri A, et al. Quality of life in Arab women with breast cancer: A review of the literature. Health Qual Life Outcomes. 2016;27:14:64. doi: 10.1186/s12955-016-0468-9
11. 11. Xu, Xue; Li, Mengzhi; Hu, Jun; Chen, Zheng; Yu, Jinyu; Dong, Yan; Sun, Chengtao; Han J. Somatic mitochondrial DNA D ‑ loop mutations in meningioma discovered : A preliminary data A comprehensive overview of mitochondrial DNA 4977-bp. J Cancer Res Ther. 2018;14(7):1525–34. doi: 10.4103/jcrt.JCRT
12. 12. Teo I, Cheung YB, Lim TYK, Namuduri RP, Long V, Tewani K. The relationship between symptom prevalence, body image, and quality of life in Asian gynecologic cancer patients. Psychooncology. 2018 Jan;27(1):69-74. doi: 10.1002/pon.4457
13. 13. Wu W, He X, Li S, Jin M, Ni Y. Pain nursing for gynecologic cancer patients. Front Oncol Front Oncol. 2023; 13: 1205553. doi: 10.3389/fonc.2023.1205553
14. 14. Song W, Eaton LH, Gordon DB, Hoyle C, Doorenbos AZ. Evaluation of Evidence-based Nursing Pain Management Practice. Pain Manag Nurs. 2015;16(4):456-63. doi: 10.1016/j.pmn.2014.09.001
15. 15. National Cancer Instıtute [Internet]. Nausea and Vomiting Related to Cancer Treatment (PDQ®) 2023 [cited 2024 Aug 15]. Available from: https://www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq#_1
16. 16. Di Mattei VE, Carnelli L, Carrara L, Bernardi M, Crespi G, Rancoita PMV, et al. Chemotherapy-induced nausea and vomiting in women with gynecological cancer. Cancer Nurs. 2016;39(6):E52–9. doi: 10.1097/NCC.0000000000000342
17. 17. Al Maqbali M, Al Sinani M, Alsayed A, Gleason AM. Prevalence of Sleep Disturbance in Patients With Cancer: A Systematic Review and Meta-Analysis. Clin Nurs Res [Internet]. 2022 Jul 1 [cited 2024 May 6];31(6):1107–23. doi:10.1177/10547738221092146.
18. 18. Zhao C, Grubbs A, Barber EL. Sleep and gynecologic cancer outcomes: Opportunities to improve quality of life and survival. Int J Gynecol Cancer. 2022 May 3;32(5):669-675. doi: 10.1136/ijgc-2022-003404.
19. 19. Grassi L, Zachariae R, Caruso R, Palagini L, Campos-Ródenas R, Riba MB, et al. Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline. ESMO Open. 2023;8(6):102047. doi: 10.1016/j.esmoop.2023.102047.
20. 20. National Cancer Instıtute [Internet]. Fatigue (PDQ®): Health Professional Version 2023 [cited 2024 May 11]. Available from: https://www.cancer.gov/about-cancer/treatment/side-effects/fatigue/fatigue-hp-pdq
21. 21. Vaz-Luis I, Di Meglio A, Havas J, El-Mouhebb M, Lapidari P, Presti D, et al. Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis. J Clin Oncol. 2022 Jul 1;40(19):2148-2162. doi: 10.1200/JCO.21.01958
22. 22. Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023. Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429
23. 23. Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, et al. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2022 Dec 1;40(34):3998-4024. doi: 10.1200/JCO.22.01357
24. 24. American Cancer Society [Internet]. Managing Fatigue or Weakness American Cancer Society 2024 [cited 2024 May 11]. Available from: https://www.cancer.org/cancer/managing-cancer/side-effects/fatigue/managing-cancer-related-fatigue.html
25. 25. Sinno AK, Pinkerton J, Febbraro T, Jones N, Khanna N, Temkin S, et al. Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Meno. Gynecol Oncol. 2020;157(2):303–6. doi:10.1016/j.ygyno.2020.01.035
26. 26. Pinkerton JA V., Aguirre FS, Blake J, Cosman F, Hodis H, Hoffstetter S, et al. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017;24(7):728–53. doi: 10.1097/GME.0000000000000921
27. 27. Hinds L, Price J. Menopause, hormone replacement and gynaecological cancers. Menopause Int. 2010;16(2):89-93. doi: 10.1258/mi.2010.010018
28. 28. Shim S, Park K-M, Chung Y-J, Kim M-R. Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements. J Menopausal Med. 2021;27(1):1-7. doi: 10.6118/jmm.20034
29. 29. Purohit P, Sassarini J, Lumsden MA. Management of Induced Menopause in Gynaecological Cancers and Their Challenges. Curr Obstet Gynecol Rep. 2019;8(3):94–102. doi:10.1007/s13669-019-0620-x
30. 30. Sopfe J, Pettigrew J, Afghahi A, Appiah LC, Coons HL. Interventions to improve sexual health in women living with and surviving cancer: Review and recommendations. Cancers (Basel). 2021 Jun 24;13(13):3153. doi: 10.3390/cancers13133153
31. 31. Mohamad Muhit AM, Sy-Cherng Woon L, Nik Mhd Nor NS, Sidi H, Mohd Kalok AH, Kampan N@. C, et al. Sexual Dysfunction among Gynaecological Cancer Survivors: A Descriptive Cross-Sectional Study in Malaysia. Int J Environ Res Public Health. 2022 Nov 23;19(23):15545. doi: 10.3390/ijerph192315545
32. 32. Sanchez Varela V, Zhou ES, Bober SL. Management of sexual problems in cancer patients and survivors. Curr Probl Cancer. 2013 Nov-Dec;37(6):319-52. doi: 10.1016/j.currproblcancer.2013.10.009
33. 33. Shankar A, Prasad N, Roy S, Chakraborty A, Biswas AS, Patil J, et al. Sexual Dysfunction in Females after Cancer Treatment: an Unresolved Issue. Asian Pac J Cancer Prev. 2017;18(5):1177. doi:10.22034/APJCP.2017.18.5.1177
34. 34. Del Pup L, Villa P, Amar ID, Bottoni C, Scambia G. Approach to sexual dysfunction in women with cancer. Int J Gynecol Cancer. 2019 Mar;29(3):630-634. doi: 10.1136/ijgc-2018-000096
35. 35. The North American Menopause Society [Internet]. Effective Treatments for Sexual Problems, Sexual Side Effects of Menopause 2024 [cited 2024 May 5]. Available from: https://www.menopause.org/for-women/sexual-health-menopause-online/effective-treatments-for-sexual-problems
36. 36. American Cancer Society [Internet]. Managing Female Sexual Problems Related to Cancer 2024 [cited 2024 May 10]. Available from: https://www.cancer.org/cancer/managing-cancer/side-effects/fertility-and-sexual-side-effects/sexuality-for-women-with-cancer/problems.html
37. 37. Wolfman W, Krakowsky Y, Fortier M. Guideline No. 422d: Menopause and Sexuality. J Obstet Gynaecol Canada. 2021;43(11):1334-1341. doi:10.1016/j.jogc.2021.09.005.
38. 38. Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int J Gynecol Cancer. 2018;28(4):641-655. doi: 10.1097/IGC.0000000000001216
39. 39. Laganà AS, La Rosa VL, Rapisarda AMC, Platania A, Vitale SG. Psychological impact of fertility preservation techniques in women withgynaecological cancer. Ecancermedicalscience. 2017; 11: ed62. doi: 10.3332/ecancer.2017.ed62
40. 40. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. Fertility preservation in women with gynaecologic cancer: the impact on quality of life and psychological well-being. Hum Fertil (Camb). 2018 Apr;21(1):35-38. doi: 10.1080/14647273.2017.1339365
41. 41. Gonçalves V, Ferreira PL, Saleh M, Tamargo C, Quinn GP. Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review. Oncologist. 2022;27(3):e251-e264. doi: 10.1093/oncolo/oyab051
42. 42. Rodolakis A, Scambia G, Planchamp F, Acien M, Di Spiezio Sardo A, Farrugia M, et al. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Int J Gynecol Cancer. 2023;33(2):208-222. doi: 10.1136/ijgc-2022-004047
43. 43. Klapheke AK, Keegan THM, Ruskin R, Cress RD. Depressive symptoms and health-related quality of life in older women with gynecologic Cancers. J Geriatr Oncol. 2020 Jun;11(5):820-827. doi: 10.1016/j.jgo.2019.10.001
44. 44. Eker A, Aslan E. Psychosocial Approach of Gynecological Cancer Patients. Hemşirelikte Eğitim ve Araştırma Derg. 2017;14(4):298–303. doi: 10.5222/HEAD.2017.298
45. 45. Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, et al. Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2023;41(28):4562-4591. doi: 10.1200/JCO.23.00857
46. 46. Chirico A, Vizza D, Valente M, Iacono M Lo, Campagna MR, Palombi T, et al. Assessing the fear of recurrence using the Cancer Worry Scale in a sample of Italian breast cancer survivors. Support Care Cancer. 2022 Mar;30(3):2829-2837. doi: 10.1007/s00520-021-06718-4
47. 47. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013 Sep;7(3):300-22. doi: 10.1007/s11764-013-0272-z
48. 48. Lin CR, Chen SC, Chang JTC, Fang YY, Lai YH. Fear of Cancer Recurrence and Its Impacts on Quality of Life in Family Caregivers of Patients with Head and Neck Cancers. J Nurs Res. 2016 Sep;24(3):240-8. doi: 10.1097/jnr.0000000000000169
49. 49. Butow PN, Bell ML, Smith AB, Fardell JE, Thewes B, Turner J, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer 2013;13:201. Available from: https://pubmed.ncbi.nlm.nih.gov/23617696/
50. 50. Badger TA, Segrin C, Crane TE, Chalasani P, Arslan W, Hadeed M, et al. Social Determinants of Health and Symptom Burden During Cancer Treatment. Nurs Res. 2023 Mar-Apr;72(2):103-113. doi: 10.1097/NNR.0000000000000636
51. 51. Karakartal D. Kanser Hastalarının Yaşadıkları Psiko-Sosyal Sorunların İncelenmesi. Uluslararası Beşeri Bilim ve Eğitim Derg [Internet]. 2018;4(9):48–62. Available from: https://dergipark.org.tr/tr/pub/ijhe/issue/39344/430193
52. 52. Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, et al. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 Jan;32(1):69-78. doi: 10.1136/ijgc-2021-002949
53. 53. Serçekuş P, Vardar O. Jinekolojik Kanserin Aile Üzerine Etkisi. Turkiye Klin J Obs Womens Heal Dis Nurs-Special Top. 2017;3(1):70–4. Available from: https://www.researchgate.net/publication/344690226_Jinekolojik_Kanserin_Aile_Uzerine_Etkisi
54. 54. Ilowite MF, Al-Sayegh H, Ma C, Dussel V, Rosenberg AR, Feudtner C, et al. The relationship between household income and patient-reported symptom distress and quality of life in children with advanced cancer: A report from the PediQUEST study. Cancer. 2018;124(19):3934–41. doi: 10.1002/cncr.31668
55. 55. Vrontaras N. Cancer Patients’ Views on the Family Changes and the Family Social Support. J Eur Psychol Students. 2018;9(1):16. doi:10.5334/jeps.403
56. 56. Pearre DC, Bota DA. Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients. Expert Rev Qual Life Cancer Care. 2018;3(1):19-26. doi: 10.1080/23809000.2018.1443811
57. 57. American Cancer Society [Internet]. Changes in Memory, Thinking, and Focus (Chemo Brain) 2024 [cited 2024 May 7]. Available from: https://www.cancer.org/cancer/managing-cancer/side-effects/changes-in-mood-or-thinking/chemo-brain.html
58. 58. Oncology Nursing Society [Internet]. Cognitive Impairment 2024 [cited 2024 May 7]. Available from: https://www.ons.org/pep/cognitive-impairment?display=pepnavigator&sort_by=created&items_per_page=50
59. 59. Kamga AM, Dumas A, Joly F, Billa O, Simon J, Poillot M, et al. Long‐Term Gynecological Cancer Survivors in Côte d’Or: Health‐Related Quality of Life and Living Conditions. Oncologist. 2019 Jul;24(7):e490-e500. doi: 10.1634/theoncologist.2018-0347
60. 60. Shirali E, Yarandi F, Ghaemi M, Montazeri A. Quality of life in patients with gynecological cancers: A web-based study. Asian Pacific J Cancer Prev. 2020;21(7):1969–75. doi: 10.31557/APJCP.2020.21.7.1969
61. 61. Sekse RJT, Dunberger G, Olesen ML, Østerbye M, Seibæk L. Lived experiences and quality of life after gynaecological cancer—An integrative review. J Clin Nurs. 2019 May;28(9-10):1393-1421. doi: 10.1111/jocn.14721
62. 62. Yeh YC. Symptom distress, stress, and quality of life in the first year of gynaecological cancers: A longitudinal study of women in Taiwan. Eur J Oncol Nurs. 2021;53(June):101984. doi:10.1016/j.ejon.2021.101984
63. 63. Rodrigues C, Gomes B, Albuquerque C. The rehabilitation of cancer patients and the role of nurses: a scoping review. Oncol Clin Pract. 2022;18(3):147–65. doi: 10.5603/OCP.2022.0018
64. 64. Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017 Jan;35(1):96-112. doi: 10.1200/JCO.2016.70.1474
65. 65. Mawardika T, Afiyanti Y, Rahmah H. Gynecological cancer inpatients need more supportive nursing care than outpatients: A comparative study. BMC Nurs. 2019;18(Suppl 1):1–6. doi: 10.1186/s12912-019-0355-x
66. 66. Uwayezu MG, Nikuze B, Maree JE, Buswell L, Fitch MI. Competencies for Nurses Regarding Psychosocial Care of Patients With Cancer in Africa: An Imperative for Action. JCO Glob Oncol. 2022;8(8). doi: 10.1200/GO.21.00240.
67. 67. Miyashita M. Chemotherapy-related cognitive impairment: What we need to know and what we can do. Asia-Pacific J Oncol Nurs. 2024;11(1):100334. doi: 10.1016/j.apjon.2023.100334